Cancer diagnoses worldwide trang 1 tải miễn phí từ tailieunhanh

"Cancer diagnoses worldwide" trang 1 - tải miễn phí từ tailieunhanh

Clinical features of cancer with unknown primary site (clinical features, treatment, prognosis of cancer with unknown primary site)

Clinical features of cancer with unknown primary site (clinical features, treatment, prognosis of cancer with unknown primary site)

7 2 1

The validity of pediatric cancer diagnoses in a population-based general cancer registry in Ontario, Canada

The validity of pediatric cancer diagnoses in a population-based general cancer registry in Ontario, Canada

8 80 1

Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: Our experience

Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: Our experience

8 88 0

Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: A clinicogenomic TCGA study

Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: A clinicogenomic TCGA study

11 1 1

The co-occurrence of both breastand differentiated thyroid cancer: Incidence, association and clinical implications for daily practice

The co-occurrence of both breastand differentiated thyroid cancer: Incidence, association and clinical implications for daily practice

10 1 1

Báo cáo khoa học:

Báo cáo khoa học: "Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients"

6 57 0

The effect of survivin gene promoter polymorphism on breast cancer

The effect of survivin gene promoter polymorphism on breast cancer

9 57 0

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer

11 27 1

Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib

Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib

8 4 1